Oneness Biotech Co., Ltd. (TPEX:4743)
Taiwan · Delayed Price · Currency is TWD 51.80
+0.80 (1.57%)
Mar 24, 2026, 1:30 PM CST
Oneness Biotech Market Cap
Oneness Biotech has a market cap or net worth of 24.4 billion as of March 23, 2026. Its market cap has decreased by -36.83% in one year.
Market Cap
24.40B
Enterprise Value
19.38B
Revenue
117.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
51.80
Market Cap Chart
Since June 22, 2009, Oneness Biotech's market cap has increased from 1.24B to 24.40B, an increase of 1,868.10%. That is a compound annual growth rate of 19.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 24.40B | -8.27% |
| Dec 31, 2025 | 26.60B | -36.18% |
| Dec 31, 2024 | 41.68B | -52.65% |
| Dec 29, 2023 | 88.03B | -7.55% |
| Dec 30, 2022 | 95.22B | -13.04% |
| Dec 30, 2021 | 109.49B | 21.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pell Bio-Med Technology | 35.19B |
| Lin BioScience | 29.70B |
| Lumosa Therapeutics | 24.29B |
| Sunmax Biotechnology | 21.30B |
| Medigen Vaccine Biologics | 17.92B |
| EirGenix | 16.98B |
| Polaris Group | 16.94B |
| AP Biosciences | 15.49B |